Literature DB >> 12428213

myotilin Mutation found in second pedigree with LGMD1A.

Michael A Hauser1, Cecilia B Conde, Valeria Kowaljow, Guillermo Zeppa, Ana L Taratuto, Udana M Torian, Jeffery Vance, Margaret A Pericak-Vance, Marcy C Speer, Alberto L Rosa.   

Abstract

Limb-girdle muscular dystrophy 1A (LGMD1A [MIM 159000]) is an autosomal dominant form of muscular dystrophy characterized by adult onset of proximal weakness progressing to distal muscle weakness. We have reported elsewhere a mutation in the myotilin gene in a large, North American family of German descent. Here, we report the mutation screening of an additional 86 families with a variety of neuromuscular pathologies. We have identified a new myotilin mutation in an Argentinian pedigree with LGMD1 that is predicted to result in the conversion of serine 55 to phenylalanine (S55F). This mutation has not been found in 392 control chromosomes and is located in the unique N-terminal domain of myotilin, only two residues from the T57I mutation reported elsewhere. Both T57I and S55F are located outside the alpha-actinin and gamma-filamin binding sites within myotilin. The identification of two independent pedigrees with the same disease, each bearing a different mutation in the same gene, has long been the gold standard for establishing a causal relationship between defects in a gene and the resultant disease. As a description of the second known pedigree with LGMD1A, this finding constitutes that gold standard of proof that mutations in the myotilin gene cause LGMD1A.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12428213      PMCID: PMC378586          DOI: 10.1086/344532

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

1.  Characterization of muscle filamin isoforms suggests a possible role of gamma-filamin/ABP-L in sarcomeric Z-disc formation.

Authors:  P F van der Ven; W M Obermann; B Lemke; M Gautel; K Weber; D O Fürst
Journal:  Cell Motil Cytoskeleton       Date:  2000-02

2.  Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene.

Authors:  Patrick Frosk; Tracey Weiler; Edward Nylen; Thangirala Sudha; Cheryl R Greenberg; Kenneth Morgan; T Mary Fujiwara; Klaus Wrogemann
Journal:  Am J Hum Genet       Date:  2002-01-29       Impact factor: 11.025

3.  Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy.

Authors:  K J Nowak; D Wattanasirichaigoon; H H Goebel; M Wilce; K Pelin; K Donner; R L Jacob; C Hübner; K Oexle; J R Anderson; C M Verity; K N North; S T Iannaccone; C R Müller; P Nürnberg; F Muntoni; C Sewry; I Hughes; R Sutphen; A G Lacson; K J Swoboda; J Vigneron; C Wallgren-Pettersson; A H Beggs; N G Laing
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

4.  A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy.

Authors:  N G Laing; S D Wilton; P A Akkari; S Dorosz; K Boundy; C Kneebone; P Blumbergs; S White; H Watkins; D R Love
Journal:  Nat Genet       Date:  1995-01       Impact factor: 38.330

5.  Myotilin is mutated in limb girdle muscular dystrophy 1A.

Authors:  M A Hauser; S K Horrigan; P Salmikangas; U M Torian; K D Viles; R Dancel; R W Tim; A Taivainen; L Bartoloni; J M Gilchrist; J M Stajich; P C Gaskell; J R Gilbert; J M Vance; M A Pericak-Vance; O Carpen; C A Westbrook; M C Speer
Journal:  Hum Mol Genet       Date:  2000-09-01       Impact factor: 6.150

6.  Interaction of filamin with f-actin in solution.

Authors:  K Wang; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

7.  Direct interaction of filamin (ABP-280) with the beta 2-integrin subunit CD18.

Authors:  C P Sharma; R M Ezzell; M A Arnaout
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

8.  Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy.

Authors:  S L Roberds; F Leturcq; V Allamand; F Piccolo; M Jeanpierre; R D Anderson; L E Lim; J C Lee; F M Tomé; N B Romero
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

9.  Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein.

Authors:  T G Thompson; Y M Chan; A A Hack; M Brosius; M Rajala; H G Lidov; E M McNally; S Watkins; L M Kunkel
Journal:  J Cell Biol       Date:  2000-01-10       Impact factor: 10.539

10.  Indications for a novel muscular dystrophy pathway. gamma-filamin, the muscle-specific filamin isoform, interacts with myotilin.

Authors:  P F van der Ven; S Wiesner; P Salmikangas; D Auerbach; M Himmel; S Kempa; K Hayess; D Pacholsky; A Taivainen; R Schröder; O Carpén; D O Fürst
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  18 in total

1.  Identification of a Novel Mutation in the Titin Gene in a Chinese Family with Limb-Girdle Muscular Dystrophy 2J.

Authors:  Wen Zheng; Han Chen; Xiong Deng; Lamei Yuan; Yan Yang; Zhi Song; Zhijian Yang; Yuan Wu; Hao Deng
Journal:  Mol Neurobiol       Date:  2015-09-21       Impact factor: 5.590

2.  Novel recessive myotilin mutation causes severe myofibrillar myopathy.

Authors:  Joachim Schessl; Elisa Bach; Simone Rost; Sarah Feldkirchner; Christiana Kubny; Stefan Müller; Franz-Georg Hanisch; Wolfram Kress; Benedikt Schoser
Journal:  Neurogenetics       Date:  2014-06-14       Impact factor: 2.660

Review 3.  Myofibrillar myopathies.

Authors:  Duygu Selcen
Journal:  Neuromuscul Disord       Date:  2011-01-20       Impact factor: 4.296

4.  Protective action of tetramethylpyrazine phosphate against dilated cardiomyopathy in cTnT(R141W) transgenic mice.

Authors:  Hai-ping Zhao; Dan Lü; Wei Zhang; Li Zhang; Shu-mei Wang; Chun-mei Ma; Chuan Qin; Lian-feng Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-02-15       Impact factor: 6.150

5.  A novel mutation in the myotilin gene (MYOT) causes a severe form of limb girdle muscular dystrophy 1A (LGMD1A).

Authors:  Peter Reilich; Sabine Krause; Nicolai Schramm; Ursula Klutzny; Stefanie Bulst; Barbara Zehetmayer; Peter Schneiderat; Maggie C Walter; Benedikt Schoser; Hanns Lochmüller
Journal:  J Neurol       Date:  2011-02-20       Impact factor: 4.849

Review 6.  [Limb girdle muscular dystrophies].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2004-12       Impact factor: 1.214

Review 7.  Myofibrillar myopathies.

Authors:  Duygu Selcen
Journal:  Curr Opin Neurol       Date:  2008-10       Impact factor: 5.710

8.  Distinct muscle imaging patterns in myofibrillar myopathies.

Authors:  D Fischer; R A Kley; K Strach; C Meyer; T Sommer; K Eger; A Rolfs; W Meyer; A Pou; J Pradas; C M Heyer; A Grossmann; A Huebner; W Kress; J Reimann; R Schröder; B Eymard; M Fardeau; B Udd; L Goldfarb; M Vorgerd; M Olivé
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

9.  Clinical phenotype, muscle MRI and muscle pathology of LGMD1F.

Authors:  Enrico Peterle; Marina Fanin; Claudio Semplicini; Juan Jesus Vilchez Padilla; Vincenzo Nigro; Corrado Angelini
Journal:  J Neurol       Date:  2013-04-30       Impact factor: 4.849

Review 10.  RNAi-based gene therapy for dominant Limb Girdle Muscular Dystrophies.

Authors:  Jian Liu; Scott Q Harper
Journal:  Curr Gene Ther       Date:  2012-08       Impact factor: 4.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.